Ginot R, Rouget B, Bensadoun H, Pasticier G, Bernhard J-C, Capon G, Ferrière J-M, Robert G
Service d'urologie et de transplantation rénale, CHU de Bordeaux, université de Bordeaux, 33076 Bordeaux, France.
Service d'urologie et de transplantation rénale, CHU de Bordeaux, université de Bordeaux, 33076 Bordeaux, France.
Prog Urol. 2016 Jun;26(8):457-63. doi: 10.1016/j.purol.2016.06.009. Epub 2016 Jul 22.
Radical cystectomy remains the referent treatment of non-metastatic muscle-invasive bladder cancer (MIBC). The fast development of robotic surgery has led some teams to use it for the surgical treatment of the MIBC, in the hope of reducing postoperative morbidity. Urinary diversion by bladder substitution is a bypass option. The aim of our study was to compare the robot-assisted cystectomy with open cystectomy, with urinary diversion by bladder substitution.
Over a two-year period, all the patients who underwent a robot-assisted laparoscopic or open cystectomy with urinary diversion by bladder substitution have been included. The urinary diversion performed was extra-corporeal.
The study concerned were 26 men, 15 of them underwent robot-assisted cystectomy, and 11 open cystectomy. There was no significant difference in the median operating time or duration of stay (300 vs 314min and 14 vs 18 days). However, there were less blood loss and more lymph nodes collected in the cystectomies robot-assisted group (median: 400 vs 800mL, P=0.016; 15 vs 10, P=0.01). Three grade III complications of the Clavien-Dindo classification have been described in the robot-assisted group, and none in the open group. No robot-assisted procedure required a conversion to laparotomy. Within 90 postoperative days, complications are basically low grades and results are consistent with the literature.
In our series, robot-assisted cystectomies with extracorporeal bladder substitution is technically feasible, with best results on blood loss and the number of lymph nodes removed, without impact on the length of stay.
根治性膀胱切除术仍然是非转移性肌层浸润性膀胱癌(MIBC)的标准治疗方法。机器人手术的快速发展促使一些团队将其用于MIBC的手术治疗,以期降低术后发病率。膀胱替代术进行尿流改道是一种替代选择。我们研究的目的是比较机器人辅助膀胱切除术与开放性膀胱切除术以及膀胱替代术进行尿流改道的情况。
在两年期间,纳入了所有接受机器人辅助腹腔镜或开放性膀胱切除术并采用膀胱替代术进行尿流改道的患者。所进行的尿流改道是体外的。
该研究涉及26名男性,其中15人接受了机器人辅助膀胱切除术,11人接受了开放性膀胱切除术。中位手术时间或住院时间无显著差异(300分钟对314分钟,14天对18天)。然而,机器人辅助膀胱切除组的失血量较少且收集的淋巴结较多(中位值:400毫升对800毫升,P = 0.016;15个对10个,P = 0.01)。机器人辅助组描述了3例Clavien-Dindo分类的III级并发症,开放组无并发症。没有机器人辅助手术需要转为开腹手术。术后90天内,并发症基本为低级别,结果与文献一致。
在我们的系列研究中,机器人辅助膀胱切除术加体外膀胱替代术在技术上是可行的,在失血量和切除的淋巴结数量方面效果最佳,且不影响住院时间。
4级。